These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 18520052

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The ubiquitously expressed human CYP51 encodes lanosterol 14 alpha-demethylase, a cytochrome P450 whose expression is regulated by oxysterols.
    Strömstedt M, Rozman D, Waterman MR.
    Arch Biochem Biophys; 1996 May 01; 329(1):73-81. PubMed ID: 8619637
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.
    Xu YX, Redon V, Yu H, Querbes W, Pirruccello J, Liebow A, Deik A, Trindade K, Wang X, Musunuru K, Clish CB, Cowan C, Fizgerald K, Rader D, Kathiresan S.
    Atherosclerosis; 2018 Jan 01; 268():196-206. PubMed ID: 29183623
    [Abstract] [Full Text] [Related]

  • 6. Cholesterogenic lanosterol 14alpha-demethylase (CYP51) is an immediate early response gene.
    Fink M, Acimovic J, Rezen T, Tansek N, Rozman D.
    Endocrinology; 2005 Dec 01; 146(12):5321-31. PubMed ID: 16123160
    [Abstract] [Full Text] [Related]

  • 7. A functional cytochrome P450 lanosterol 14 alpha-demethylase CYP51 enzyme in the acrosome: transport through the Golgi and synthesis of meiosis-activating sterols.
    Cotman M, Jezek D, Fon Tacer K, Frangez R, Rozman D.
    Endocrinology; 2004 Mar 01; 145(3):1419-26. PubMed ID: 14630712
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The three human cytochrome P450 lanosterol 14 alpha-demethylase (CYP51) genes reside on chromosomes 3, 7, and 13: structure of the two retrotransposed pseudogenes, association with a line-1 element, and evolution of the human CYP51 family.
    Rozman D, Strömstedt M, Waterman MR.
    Arch Biochem Biophys; 1996 Sep 15; 333(2):466-74. PubMed ID: 8809088
    [Abstract] [Full Text] [Related]

  • 10. Altered gene expression of hepatic lanosterol 14alpha-demethylase (CYP51) in lead nitrate-treated rats.
    Kojima M, Nemoto K, Murai U, Yoshimura N, Ayabe Y, Degawa M.
    Arch Toxicol; 2002 Jul 15; 76(7):398-403. PubMed ID: 12111004
    [Abstract] [Full Text] [Related]

  • 11. Azalanstat (RS-21607), a lanosterol 14 alpha-demethylase inhibitor with cholesterol-lowering activity.
    Burton PM, Swinney DC, Heller R, Dunlap B, Chiou M, Malonzo E, Haller J, Walker KA, Salari A, Murakami S.
    Biochem Pharmacol; 1995 Aug 08; 50(4):529-44. PubMed ID: 7646560
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of the mouse lanosterol 14alpha-demethylase (CYP51), a new member of the evolutionarily most conserved cytochrome P450 family.
    Debeljak N, Horvat S, Vouk K, Lee M, Rozman D.
    Arch Biochem Biophys; 2000 Jul 01; 379(1):37-45. PubMed ID: 10864439
    [Abstract] [Full Text] [Related]

  • 18. cDNA cloning, genomic structure and expression analysis of the bovine lanosterol 14alpha-demethylase (CYP51) in gonads.
    Wang F, Shen Y, Song X, Xia G, Chen X, Zhou B, Lei L.
    Biol Pharm Bull; 2006 Mar 01; 29(3):430-6. PubMed ID: 16508140
    [Abstract] [Full Text] [Related]

  • 19. Insulin is the essential factor maintaining the constitutive expression of hepatic sterol 14-demethylase P450 (CYP51).
    Yamashita C, Kudo M, Ishida H, Noshiro M, Aoyama Y, Yoshida Y.
    J Biochem; 2000 Jul 01; 128(1):93-9. PubMed ID: 10876162
    [Abstract] [Full Text] [Related]

  • 20. Hidden disease susceptibility and sexual dimorphism in the heterozygous knockout of Cyp51 from cholesterol synthesis.
    Lewinska M, Juvan P, Perse M, Jeruc J, Kos S, Lorbek G, Urlep Z, Keber R, Horvat S, Rozman D.
    PLoS One; 2014 Jul 01; 9(11):e112787. PubMed ID: 25393872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.